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Abstract
Background: This study sought to synthesize survival outcomes from trials of laparoscopic and open colorectal cancer
surgery, and to determine whether expert acceptance of this technology in the literature has parallel cumulative survival
evidence.
Study Design: A systematic review of randomized trials was conducted. The primary outcome was survival, and meta-
analysis of time-to-event data was conducted. Expert opinion in the literature (published reviews, guidelines, and textbook
chapters) on the acceptability of laparoscopic colorectal cancer was graded using a 7-point scale. Pooled survival data were
correlated in time with accumulating expert opinion scores.
Results: A total of 5,800 citations were screened. Of these, 39 publications pertaining to 23 individual trials were retained. As
well, 414 reviews were included (28 guidelines, 30 textbook chapters, 20 systematic reviews, 336 narrative reviews). In total,
5,782 patients were randomized to laparoscopic (n = 3,031) and open (n = 2,751) colorectal surgery. Survival data were
presented in 16 publications. Laparoscopic surgery was not inferior to open surgery in terms of overall survival (HR = 0.94,
95% CI 0.80, 1.09). Expert opinion in the literature pertaining to the oncologic acceptability of laparoscopic surgery for colon
cancer correlated most closely with the publication of large RCTs in 2002–2004. Although increasingly accepted since 2006,
laparoscopic surgery for rectal cancer remained controversial.
Conclusions: Laparoscopic surgery for colon cancer is non-inferior to open surgery in terms of overall survival, and has been
so since 2004. The majority expert opinion in the literature has considered these two techniques to be equivalent since
2002–2004. Laparoscopic surgery for rectal cancer has been increasingly accepted since 2006, but remains controversial.
Knowledge translation efforts in this field appear to have paralleled the accumulation of clinical trial evidence.
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Introduction
Laparoscopic surgical techniques were first introduced as a
treatment for colorectal pathologies in 1991 [1,2]. Since this
pioneering work, an abundance of literature has detailed the
application of this technology to both benign and malignant
colorectal disorders [3]. In the early days, surgeons readily
embraced laparoscopic surgery for benign colorectal conditions
such as diverticulitis and inflammatory bowel disease, on the basis
of perceived improvements in length of stay in hospital,
postoperative pain, bowel function, and return to normal activities,
as well as obvious cosmetic advantages [3–5]. On the other hand,
the adoption of laparoscopic surgery to treat colorectal cancer has
lagged behind that of benign conditions, and has been highly
controversial over the last twenty years.
As with any malignant disorder, novel surgical technologies
used to treat patients with curable colorectal cancer must be
demonstrated to achieve improved or, at a minimum, equivalent
survival outcomes. While surgical innovation has often relied on a
trial-and-error approach, many surgeon-scientists now argue that
novel technologies must be scrutinized carefully and tested using
robust research methods [6]. It is widely agreed that randomized
controlled trials (RCTs) provide the highest standard of evidence
in evaluating healthcare interventions. In this context, it is not
surprising that several RCTs comparing laparoscopic and open
surgery for colorectal cancer have been conducted over the years,
many of which have now yielded long-term oncologic outcomes.
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In spite of an abundance of published data, both RCTs and
observational studies, it remains unclear whether surgeons have
adopted this novel technology on the basis of published high-level
survival evidence. In this context, the objective of this work was to
synthesize survival outcomes from RCTs of laparoscopic and open
colorectal cancer surgery, and to determine whether expert
acceptance of this technology in the literature has parallel
cumulative survival evidence from clinical trials.
Materials and Methods
The body of literature required to answer the research question
was obtained using systematic review techniques. In the first part
of this work, trials were identified and survival data were meta-
analyzed. In the second part, review articles were identified and
used to grade expert opinions regarding the acceptability of
laparoscopy in treating colorectal cancer. Finally, both parts of this
work were combined, by comparing accumulating survival data
and expert opinions over time. A systematic review protocol was
written and followed.
Systematic Review
RCTs and review articles were included, on the basis of pre-
determined inclusion and exclusion criteria. All RCTs pertained to
patients with primary carcinoma of the colon or rectum of any
stage. The primary intent of the citation had to address the
treatment of colorectal cancer specifically. Included patients had to
undergo a segmental resection of the colon or rectum by
laparoscopic or hand-assisted laparoscopic surgery. The control
intervention was open surgery. To be considered for inclusion,
citations had to provide data on the primary outcome of overall
survival. Trials not reporting overall survival were not included in
the meta-analysis, but were retrieved to allow for the complete
identification of RCTs.
For review papers, inclusion criteria were purposely less strictly
defined so as to capture the entire spectrum of publications
pertaining to the laparoscopic treatment of colorectal cancer.
Acceptable review articles were narrative reviews, systematic
reviews/meta-analyses, textbook chapters, and guidelines/policy
statements. Reviews were included unless they were limited to
single specific outcomes other than oncologic outcomes (eg.
postoperative pain). All reviews addressing the surgical care of
colorectal cancer in general terms were included, as a lack of
discussion of laparoscopy would indicate that the authors did not
consider it relevant.
A comprehensive search strategy was designed to identify both
primary literature and review citations (see Text S1). This search
strategy was designed to be highly sensitive, and was modified
from previously published work [7]. Six major databases were
searched for relevant citations from 1991–2008 (Ovid MED-
LINE, Ovid EMBASE, Cochrane Library, Science Citation
Index Expanded, BIOSIS Preview, and BIREME LILACS). An
additional thirteen databases were also searched for relevant
citations (Database of Abstracts of Reviews of Effectiveness,
Heath Technology Assessment Database, NHS Economic
Evaluation Database, NIHR Health Technology Assessment
Programme, Trip Database, Clinicaltrials.gov, Controlled-trials.-
com, National Guidelines Clearinghouse, CMA Infobase:
Clinical Practice Guidelines, NICE England, SIGN Scotland,
NHMRC Australia, New Zealand Guidelines Group). In
addition, all editions of nine major surgical textbooks published
since 1991 were included for consideration (Schwartz’s Principles
of Surgery, Sabiston Textbook of Surgery, Greenfield’s Surgery,
Cameron’s Current Surgical Therapy, Shackelford’s Surgery of
the Alimentary Tract, Mastery of Surgery, Gordon’s Surgery of
the Colon, Rectum and Anus, Corman’s Colon and Rectal
Surgery, and Fazio’s Current Therapy in Colon & Rectal
Surgery). The reference lists of all included citations were
screened to identify missing trials and reviews. No language
limitation was applied to the search strategy.
All citation records were retrieved and downloaded electroni-
cally using Reference Manager 10 (ISI ResearchSoft, Berkeley,
CA), and were then de-duplicated manually. All citations were first
screened for inclusion on the basis of titles and abstracts (figure 1).
All retained citations were then retrieved in full text. Papers
published in languages other than English, French, or Spanish
were translated in full. Citations in Asian languages included after
the first screen had to be excluded from further consideration due
to translation resource limitations. Full-text articles were evaluated
for inclusion.
Included RCTs were examined their risk of bias using the
approach advocated by the Cochrane Collaboration [8]. Eight
items were appraised: 1) random sequence generation, 2)
allocation concealment, 3) blinding of participants and personnel,
4) blinding of outcome assessment, 5) incomplete outcome data, 6)
selective reporting, 7) provider expertise bias (surgical skills
acquisition and learning curves can influence outcomes in
procedures-based trials [9]) and 8) other potential sources of bias
(eg. randomization after carrying out a diagnostic laparoscopy).
All eight items were assessed for each trial. Where trials had
more than one publication, the trial as a whole as evaluated using
all included reports. As well, referenced trial protocols or partial
publications not included in this review were also read in an
attempt to minimize trial reporting issues. All items were graded as
‘‘low risk of bias’’, ‘‘high risk of bias’’, or ‘‘unclear risk of bias’’.
These data were synthesized using descriptive figures. Trials with
five or more items with a low risk of bias were arbitrarily defined as
high-quality studies.
Data Analysis
Data from included RCTs and review papers were extracted.
Data points were checked for accuracy by a second reviewer and
discrepancies were resolved by consensus. Although each citation
was abstracted separately, trials with multiple publications were
identified so as to avoid patient duplication. Individual trial
authors were contacted selectively.
Data on overall survival were abstracted in the statistical format
provided in individual reports. Relative outcomes were always
recorded as a comparison of laparoscopic to open surgery. Where
hazard ratios (HR) for survival and confidence intervals were not
provided, available data were utilized to generate hazard ratios for
each trial using published methods [10–12]. Briefly, this technique
allows one to derive the ln(HR) and var(ln(HR)) from published
statistics. Where this information is unavailable, one can utilize
Kaplan-Meier curves to derive conservative estimates of HR. This
method assumes that censoring is constant and non-informative
across smaller time interval on the Kaplan-Meier curve (eg. 6
months). A Microsoft Excel (Microsoft Corporation, Richmond,
WA) macro was utilized to facilitate all computations [12,13].
Expert opinion in the literature was abstracted from review
papers separately for colon and rectal cancers. The author’s global
conclusion regarding the acceptability of laparoscopic surgery to
treat colon or rectal cancer was extracted. Where multiple
conclusions were provided within a single review, the expert
author’s opinion regarding the primary outcome of overall survival
was considered. Each review paper’s conclusion was graded on a
seven-point asymmetric scale, ranging from 1, where laparoscopy
was not mentioned in a review paper pertaining to colorectal
Acceptance of Laparoscopic Colorectal Surgery
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cancer surgery, to 7, whereby laparoscopy was deemed the
standard of care. The other options on the scale were as follows: 2)
laparoscopy is inferior, 3) laparoscopy is acceptable only within
clinical trials, 4) laparoscopy is equivalent with anatomic
limitation, 5) laparoscopy is equivalent among experts, and 6)
laparoscopy is equivalent in routine clinical practice. For data
synthesis, options 1–2 were considered to indicate that laparoscopy
was ‘‘inferior’’ to open surgery, option 3 was considered to
describe clinical equipoise, while options 4–6 were deemed to
indicate that laparoscopy was ‘‘equivalent’’ to open surgery. This
scale was piloted independently by two reviewers using ten distinct
review articles for ease of use and congruence among reviewers.
The primary outcome of overall survival analyzed using
standard meta-analytic techniques. Derived HR were pooled
using inverse variance methods and random effects models.
Random effects models were preferred in this work because of
the often non-standardized nature of surgery across trials, the
variability in trial quality, and the added statistical conservatism
provided by this approach. Where multiple publications of the
same RCT were identified, only the most mature survival data
were used in this meta-analysis. In contrast, a cumulative random
effects meta-analysis of the primary outcome was also carried out
using the earliest available survival data set for each trial, so as to
assess the evolution of this outcome in time. Statistical measures of
heterogeneity (Cochran’s Q and I2) were obtained from fixed
effects models. Pre-specified sensitivity analyses were carried out
based on the inclusion of colon and/or rectal cancer patients, and
based on the risk of bias assigned to each trial. All analyses were
carried out using Comprehensive Meta-Analysis 2.2 (Biostat,
Englewood, NJ).
Grades of opinion for individual review papers were synthesized
as yearly proportions, and plotted as a time series. Changing
Figure 1. PRISMA flow diagram.
doi:10.1371/journal.pone.0035292.g001
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trends in expert opinions were then evaluated visually from these
graphs and correlated qualitatively with overall survival data
derived from RCTs, as well as compared to the temporal data
obtained from the cumulative meta-analysis of overall survival.
Results
A total of 5,800 single citations were evaluated (figure 1). After
screening, a total of 38 reports pertaining to 23 individual RCTs
were included [14–51] (see Table S1). A report of long-term data
pertaining to a trial already included was also included, as it
became available a few weeks after study selection [52]. In
addition, 414 review citations were included, comprising 336
narrative reviews, 30 textbook chapters, 28 guidelines/position
statements, and 20 systematic reviews. The full reference list is
available upon request.
Among 23 individual RCTs, 5 (22%) were multicenter in
design. The smallest multicenter study recruited 3 centers in
Greece [41], whereas the largest multinational RCT included 48
centers across the United States and Canada [24,26,31,45].
Patient recruitment varied widely, ranging from 28 patients for the
smallest study from Brazil [29] to 1,082 patients for the European
COLOR trial [35,43,52]. In total, 5,782 patients were randomized
between laparoscopic (n = 3,031) and open (n = 2,751) surgery as a
primary treatment for colorectal cancer. Among these patients,
58% (n= 3,336) were included as part of trials addressing only
colon cancer, whereas 10% (n= 582) took part in trials limited to
rectal cancer. The remainder of patients (32%, n= 1,864), were
included in trials addressing colorectal cancer in general, with
varying definitions as it pertains to the inclusion of rectal cancer
patients.
Among the 414 review papers included in this work, 362 (87%)
and 332 (80%) provided data pertaining to colon and rectal
cancer, respectively. Most reviews (67%, n= 280) addressed both
cancer types concurrently.
A total of eight risk of bias items were assessed individually
(figure 2). Both items pertaining to selection bias (random
sequence generation and allocation concealment), demonstrated
the lowest overall risk of bias, with each item being addressed
adequately by 57% of trials (n = 13), and all other trials lacking
sufficient information to render judgment. Similarly, the issue of
provider expertise was addressed satisfactorily by 43% of trials
(n = 10), with inadequate reporting in the remainder of studies.
Incomplete outcome reporting and selective reporting both also
yielded a low risk of bias in 43% of trials, but these items also
generated a high risk of bias in 22% and 9% of trials, respectively.
In contrast, blinding – whether of patients, study personnel, or
outcome assessors – was almost universally not attempted, yielding
a high risk of bias in all trials except for three (13%) groups that
employed blinded assessors of their primary outcomes. Two trials
also demonstrated other high risks of bias, as they elected to carry
out a diagnostic laparoscopy prior to randomization so as to
determine whether individual patients could undergo a formal
oncologic colorectal resection by laparoscopy [16–18,20,21].
Analysis of risk of bias judgments at the individual study level
identified three trials that achieved ‘‘low risk of bias’’ marks for at
least five items [24,26,31,35,43,45,51,52]. These three trials were
all large-scale multicenter multinational RCTs, contributing a
total of 2,721 patients to this review. Seven trials obtained four
‘‘low risk of bias’’ marks, as certain items could not be adequately
assessed from available trial reports, study protocols, or adjunct
publications. Finally, 11 trials obtained a total of two or less ‘‘low
risk of bias’’ marks, highlighting a greater overall risk of bias based
on reported information. Among these, six trials obtained at least
three ‘‘high risk of bias’’ marks [15–18,20,21,23,27,28], of which
five trials did not carry out intention-to-treat analyses.
Data pertaining to overall survival were presented in 16 (41%)
publications, originating from 13 (56%) individual trials. Median
follow-up time among these trials ranged from 12–95 months.
One trial did not report a median follow-up time period for either
intervention group [32]. Seven trials presented sufficient data to
obtain hazard ratios. Assuming a minimal clinically significant
margin of 10% (HR 1.1), laparoscopic surgery for colorectal
cancer was found to be non-inferior to open surgery in terms of
overall survival after pooling the most mature trial data available
(HR=0.94, 95% CI 0.80, 1.09) (figure 3a). There was no evidence
of statistical heterogeneity (Q= 8.996, p = 0.255; I2 = 22%). A
cumulative meta-analysis using overall survival data as they
became available in time for each trial yielded a comparable
hazard ratio of 0.93 (95% CI 0.81, 1.06) (figure 3b). Stability of the
pooled HR and confidence interval was achieved after publication
of the COST trial in 2004 [31].
Pooling studies including only colon cancer patients (n = 5)
yielded a HR of 1.01 (95% CI 0.86, 1.19), with no significant
statistical heterogeneity (Q= 4.762, p= 0.313; I2 = 16%). The
addition of a sixth trial, which included both sigmoid colon and
high rectal cancers, did not alter these data significantly (not
shown). Pooling trials including only rectal cancer patients (n = 2)
yielded a HR of 0.70 (95% CI 0.49, 1.00), with no statistical
heterogeneity (Q= 0.174, p= 0.676; I2 = 0%). The addition of a
third trial including only rectosigmoid cancer patients to the rectal
cancer group yielded a HR of 0.75 (95% CI 0.57, 0.99, I2 = 0%).
Pooling of the two trials with the lowest risk of bias did not
significantly alter the results (HR=1.06, 95% CI 0.89, 1.25,
I2 = 0%). Similarly, pooling all trials except one with the greatest
risk of bias did not alter the outcomes, but it did increase the
degree of statistical heterogeneity (HR=0.93, 95% 0.79, 1.09,
I2 = 28%). Pre-specified sensitivity analyses based on the risk of
bias did not significantly affect the survival results or the degree of
heterogeneity (data not shown).
Data on the number of lymph nodes harvested with the surgical
specimen was reported by 19/23 trials (83%). Nine trials presented
sufficient data to allow for meta-analysis. The range of reported
lymph nodes harvested was 5.5–23.0 for laparoscopy, and 7.8–
26.0 for open surgery. The pooled weighted mean difference
between laparoscopic and open resection was 20.17 lymph nodes
(95% CI 20.35, 0.011). This result was highly statistically
heterogeneous (Q= 22.64, p= 0.004; I2 = 65%). A sensitivity
analysis limited to colon resections yielded a similar mean
difference (20.241, 95% CI 20.632, 0.150), but with increased
heterogeneity (Q= 22.44, p , 0.001; I2 = 82%), indicating that
much of the statistical variation originates with trials addressing
colon cancer rather than colorectal or rectal cancer. Analysis of
rectal cancer trials (n = 2) eliminated this statistical heterogeneity
(mean difference 20.129, 95% CI 20.461, 0.203, I2 = 0%). The
addition of trials addressing colorectal cancer to those limited to
rectal cancer yielded a statistically significant mean difference of
20.142 (95% CI 20.271, 20.014), with no statistical heteroge-
neity (Q= 0.185, p = 0.980; I2 = 0%). Finally, excluding high-risk
of bias trials from the pooling yielded a mean difference of 20.106
(95% CI 20.211, 0.000, p = 0.05), with no evidence of statistical
heterogeneity (Q= 0.974, p = 0.914, I2 = 0%).
Distinct trends in expert opinions were identified for colon and
rectal cancer. For colon cancer (figure 4), laparoscopy was initially
considered inferior to open surgery, with 100% and 75% of expert
opinions scoring ‘‘inferior’’ in 1991 and 1992, respectively. As of
1993, expert opinions curves were found to shift towards
equipoise, with well over 75% of reviews opinionating that
Acceptance of Laparoscopic Colorectal Surgery
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Figure 2. Global risk of bias assessment divided by individual items.
doi:10.1371/journal.pone.0035292.g002
Figure 3. Meta-analysis of overall survival (random-effects models). a) Standard technique; b) Cumulative technique.
doi:10.1371/journal.pone.0035292.g003
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laparoscopic surgery could be considered for colon cancer in the
context of prospective trials. This trend was maintained until 2003.
Starting in 2003, a second major shift in opinions can be
identified, as experts were found to consider laparoscopic surgery
equivalent to open surgery in growing proportions. As of 2005,
opinion curves were found to have crossed over, with a majority of
surgeons favoring equivalency between the two technologies. After
1993, almost no surgeons considered laparoscopy inferior to
laparotomy. Similarly, only four reviewers considered laparoscopy
superior to open surgery at any given time point.
For rectal cancer (figure 5), experts initially considered
laparoscopy inferior to open surgery in 1991–1992. A shift
towards equipoise was again noted – albeit not as strongly – from
1993–2006 with 50–78.6% of expert considering laparoscopy
appropriate within clinical trials. In contrast to colon cancer,
experts continued to consider laparoscopy inferior to open surgery
in variable proportions (20.7–50%) from 1993–2004. A much
smaller proportion of experts began to regard laparoscopy as
equivalent to laparotomy for rectal cancer in 2003 onwards,
although the rise was much more gradual than for colon cancer.
Discussion
We have conducted a systematic review and meta-analysis of
trials comparing laparoscopic and open surgery for colorectal
cancer, addressing the primary outcome of overall survival. In
addition, we have synthesized expert opinion on this topic by
utilizing the entire body of relevant review literature as a surrogate
for the acceptability of this technology among surgeons.
In summary, this work identified 23 RCTs presented in 39
distinct published reports comparing laparoscopic and open
surgery for patients suffering from colorectal cancer. A meta-
analysis of time-to-event data on overall survival demonstrated the
non-inferiority of laparoscopy. Although other groups have also
previously conducted meta-analyses pertaining to oncologic
outcomes [53], most have opted to pool survival data using the
proportion of patients alive or dead at maximal follow-up. This
approach has the potential to introduce bias in a meta-analysis, as
the pooling of such a dichotomous outcome involves the
combination of trials at different stages of maturity and completely
omits information pertaining to the timing of death following
cancer surgery. In order to circumvent these issues, we have
pooled hazard ratios, which are more appropriate measures of
time-to-event data. Unfortunately, these data are not always
reported in clinical trials. As such, we have utilized a combination
of published data on hazard ratios where possible, together with
best estimations of HR obtained from published survival curves.
This statistical approach allowed us to generate the most
comprehensive and rigorous meta-analysis of survival data
pertaining to laparoscopic and open surgery for colorectal cancer
available to date, as well as to confirm the non-inferiority of
laparoscopy. These results compare favorably with existing meta-
analyses [53], including those that employed similar statistical
methods [54,55]. The current review is also unique in its
utilization of cumulative meta-analytic techniques and its com-
parison to expert opinion.
In addition to the above finding, we have also demonstrated
that expert opinion pertaining to laparoscopic surgery for colon
cancer shifted dramatically in 2003–2004. For rectal cancer, a
similar – albeit weaker – trend was noted in 2006. In both
instances, the majority opinion deemed that laparoscopic surgery
was equivalent to open surgery after a long period of time during
which this technique had reached clinical equipoise and was
considered only acceptable in clinical trials. We argue that the
abrupt shift in opinion in 2003 was a direct result of the
publication of the first moderate-size RCT by Lacy and colleagues
that presented medium-term survival data [25]. This single-center
trial from Barcelona randomized 219 patients to laparoscopic and
open surgery for colon cancer and argued that laparoscopy was
superior to open surgery in terms of postoperative morbidity,
length of hospital stay, tumor recurrence, and cancer-related
survival. Overall survival was also found to be superior in an
adjusted Cox model, but only trended towards significance in
unadjusted data. Despite more modest long-term results [48], this
paper was undoubtedly seminal in shifting expert opinion
regarding laparoscopy colon cancer surgery. Finally, we also
argue that this transition was further promoted by the publication
in 2004 of the COST trial, for which the influence was probably
Figure 4. Temporal summary of expert opinion in the literature pertaining to laparoscopic surgery for colon cancer.
doi:10.1371/journal.pone.0035292.g004
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greatest in North America where this trial was funded and
conducted [31].
The above argument is further supported by the results of the
cumulative meta-analysis for overall survival. Indeed, the accu-
mulation of survival data presented in figure 3b demonstrates that
both the magnitude and precision of the survival HR has stabilized
and remained essentially unchanged since publication of the
COST trial 3-year data [31]. In other words, both portions of the
current study would indicate that laparoscopic surgery for colon
cancer has been non-inferior to open surgery since 2004, and that
the surgical literature has been supportive of this finding since
2003. Taken together, these data provide a first example of
pragmatic knowledge translation in surgery based on clinical trial
evidence.
Regarding rectal cancer surgery, it is not surprising that a
notably weaker transition in expert opinion did not occur before
2006, as neither the Lacy [25] nor COST [31] trials included any
rectal cancer patients. Although some surgeons may have
extrapolated from the data on colon cancer, this is unlikely to
have affected the prevailing expert opinion in the literature. In
2005, however, the CLASICC trial from the UK included 381
(48%) patients with rectal cancer [34], and it is likely that this
paper had an encouraging influence on expert opinion. Although
survival data from this trial were not published until 2007 [44], we
argue that this publication together with mounting evidence of
non-inferiority for laparoscopic colon cancer surgery began the
transition for rectal cancer. That being said, since 2005, only a
fraction of patients enrolled in trials of laparoscopic and open
surgery have done so for rectal cancer, and it likely that many
experts in the field have continued to wait for the publication of
further large scale trials addressing this topic. Many surgeons
argue that rectal cancer patients included in trials thus far have
been carefully selected and have not been representative of
challenging mid- to low-rectal lesions [50]. For this reason, it is
likely that a full shift from equipoise to equivalency will await
results from the ongoing COLOR II [56], ACOSOG Z6051 [57]
rectal cancer trials.
There are several limitations to this study. First, our meta-
analysis of survival outcomes is limited on the basis of incomplete
reporting of data within primary publications. Although we have
utilized statistical methods to generate estimates of hazard ratios in
order to complete published data, it remains that there were
relatively few trials with sufficient long-term data. A second
limitation pertains to comparisons between colon and rectal
cancers. Although we have pooled survival data for colorectal
cancer as a whole, we have also provided sensitivity analyses to
account for the important clinical differences between the two
cancer types. Our analysis was limited by the relatively small
number of patients with rectal cancer included in trials to date. In
the absence of individual patient data, which is impractical for 23
distinct surgical trials, the methods used in the current review
represent the most robust option for pooling survival data.
Limitations pertaining to our analysis of expert opinion in the
literature include a certain degree of subjectivity in grading
included review citations, as well as a lack of formal validation of
our grading scale. We have attempted to minimize these
limitations by piloting the scale prior to implementation. As well,
we have constructed a scale that holds great face validity from a
clinical standpoint and that reflects terminology and issues that are
commonly raised in the in literature on this topic. Finally, it should
be mentioned that this type of analysis and semi-quantitative
correlation with our meta-analysis cannot determine with certainty
the precise reason for shifts in expert opinion, as our evaluation of
individual reviews did not seek to capture the reasoning behind
opinions. As well, this work has sought to capture only indirect
evidence of the adoption of laparoscopic surgery for colorectal
cancer. Proof of adoption would indeed require data on actual
uptake by surgeons rather than the utilization of a surrogate in the
literature. Nevertheless, we argue that the current analysis is highly
valuable as it provides a global evaluation of the state of the
literature on this topic, which is presumably used by many – if not
most – surgeons in evaluating novel technologies. At the very least,
this analysis provides important insight into the process of
knowledge translation by which a surgical technology is intro-
duced and subsequently taken up into practice.
In conclusion, a large number of trials comparing laparoscopic
and open surgery for colorectal cancer can be identified in the
literature. Laparoscopic surgery for colon cancer is not inferior to
Figure 5. Temporal summary of expert opinion in the literature pertaining to laparoscopic surgery for rectal cancer.
doi:10.1371/journal.pone.0035292.g005
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open surgery in terms of overall survival, and has been so since
2004. The majority expert opinion in the literature has considered
these two techniques to be equivalent, since the publication of
landmark clinical trials in 2002 and 2004. Although increasingly
accepted since 2006, laparoscopic surgery for rectal cancer
remains controversial, likely owing to the current lack of dedicated
large-scale randomized controlled trials. Knowledge translation
efforts in the field of laparoscopic surgery for colorectal cancer
appear to have paralleled the accumulation of clinical trial
evidence.
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